Jonathan Spergel, MD, PhD, on Epicutaneous Immunotherapy for Pediatric Milk-Induced Eosinophilic Esophagitis
08/13/2019
Jonathan Spergel, MD, PhD, from Children’s Hospital of Philadelphia, discusses the current management of milk-induced eosinophilic esophagitis (EoE) among children, his study that evaluated epicutaneous immunotherapy as a potential treatment option, and more.
Jonathan Spergel, MD, PhD, is a professor of pediatrics and chief of the Allergy Section, Division of Allergy and Immunology, at Children’s Hospital of Philadelphia.
Reference:
Spergel JM, Elci OU, Muir AB, et al. Efficacy of epicutaneous immunotherapy in children with milk-induced eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;pii:S1542-3565(19)30524-30525. doi:10.1016/j.cgh.2019.05.014.